Dr. Prem Soman and Dr. C. Michael Gibson Discuss: Long-Term Survival Benefits and Disease Stabilization With Acoramidis In Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) March 30, 2026 2026 | ACC | Cardiology | Slides | Trial | Video SomanDownload Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc. Article Navigation Dr. Victoria Parikh and Dr. C. Michael Gibson Discuss: Safety and Preliminary Efficacy of AAVrh.10hPKP2 (LX2020) Gene Therapy in PKP2- Arrhythmogenic Cardiomyopathy Dr. Neha Pagidipati and Dr. C. Michael Gibson discuss how the new lipid guidelines are moving the needle on LDL lowering: earlier, lower, longer.
